{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T03:12:05Z","timestamp":1792293125385,"version":"4.4.0"},"reference-count":174,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pathology - Research and Practice"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.prp.2024.155172","type":"journal-article","created":{"date-parts":[[2024,1,26]],"date-time":"2024-01-26T14:25:45Z","timestamp":1706279145000},"page":"155172","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Stem cell therapy for HTLV-1 induced adult T-cell leukemia\/lymphoma (ATLL): A comprehensive review"],"prefix":"10.1016","volume":"255","author":[{"given":"Amir","family":"Gholamzad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niloofar","family":"Khakpour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehrdad","family":"Gholamzad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Reza","family":"Roudaki Sarvandani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elaheh Mohandesi","family":"Khosroshahi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saba","family":"Asadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohsen","family":"Rashidi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehrdad","family":"Hashemi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.prp.2024.155172_bib1","first-page":"17","article-title":"Mogamulizumab for the treatment of adult T-cell leukemia\/lymphoma","author":"Yoshimitsu","year":"2014","journal-title":"Blood Lymphat. Cancer.: Targets Ther."},{"issue":"3","key":"10.1016\/j.prp.2024.155172_bib2","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1007\/s00277-020-03934-6","article-title":"Reduced-intensity haploidentical peripheral blood stem cell transplantation using low-dose thymoglobulin for aggressive adult T cell leukemia\/lymphoma patients in non-complete remission","volume":"99","author":"Hirosawa","year":"2020","journal-title":"Ann. Hematol."},{"issue":"3","key":"10.1016\/j.prp.2024.155172_bib3","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/s12185-009-0406-2","article-title":"Successful treatment of young-onset adult T cell leukemia\/lymphoma and preceding chronic refractory eczema and corneal injury by allogeneic hematopoietic stem cell transplantation","volume":"90","author":"Miyamura","year":"2009","journal-title":"Int. J. Hematol."},{"issue":"21","key":"10.1016\/j.prp.2024.155172_bib4","doi-asserted-by":"crossref","first-page":"2757","DOI":"10.2169\/internalmedicine.5077-20","article-title":"Adult T-cell leukemia-lymphoma with primary breast involvement: a case report and literature review","volume":"59","author":"Kobayashi","year":"2020","journal-title":"Intern. Med."},{"issue":"9","key":"10.1016\/j.prp.2024.155172_bib5","doi-asserted-by":"crossref","first-page":"5237","DOI":"10.21873\/anticanres.14527","article-title":"Mogamulizumab Plus EPOCH Therapy for Patients With Newly Diagnosed Aggressive Adult T-cell Leukemia\/lymphoma","volume":"40","author":"Jo","year":"2020","journal-title":"Anticancer Res."},{"issue":"6","key":"10.1016\/j.prp.2024.155172_bib6","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1038\/sj.leu.2404678","article-title":"Small number of HTLV-1-positive cells frequently remains during complete remission after allogeneic hematopoietic stem cell transplantation that are heterogeneous in origin among cases with adult T-cell leukemia\/lymphoma","volume":"21","author":"Yamasaki","year":"2007","journal-title":"Leukemia"},{"issue":"1","key":"10.1016\/j.prp.2024.155172_bib7","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1002\/hon.2558","article-title":"The outcome and characteristics of patients with relapsed adult T cell leukemia\/lymphoma after allogeneic hematopoietic stem cell transplantation","volume":"37","author":"Kato","year":"2019","journal-title":"Hematol. Oncol."},{"issue":"11","key":"10.1016\/j.prp.2024.155172_bib8","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.1002\/1097-0142(19890601)63:11<2186::AID-CNCR2820631121>3.0.CO;2-J","article-title":"Human T-cell leukemia virus-I and hematologic malignancies in Panama","volume":"63","author":"Levine","year":"1989","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.prp.2024.155172_bib9","doi-asserted-by":"crossref","first-page":"9","DOI":"10.7889\/hct-18-010","article-title":"The role of immunotherapy in patients with adult T-cell leukemia\/lymphoma","volume":"8","author":"Kato","year":"2019","journal-title":"J. Hematop. Cell Transplant."},{"issue":"13","key":"10.1016\/j.prp.2024.155172_bib10","doi-asserted-by":"crossref","first-page":"3097","DOI":"10.1182\/blood-2011-09-379982","article-title":"Cancer\/testis antigens are novel targets of immunotherapy for adult T-cell leukemia\/lymphoma","volume":"119","author":"Nishikawa","year":"2012","journal-title":"Blood"},{"issue":"14","key":"10.1016\/j.prp.2024.155172_bib11","doi-asserted-by":"crossref","first-page":"3911","DOI":"10.1182\/blood-2010-12-319467","article-title":"FERM domain mutations induce gain of function in JAK3 in adult T-cell leukemia\/lymphoma","volume":"118","author":"Elliott","year":"2011","journal-title":"Blood"},{"issue":"13","key":"10.1016\/j.prp.2024.155172_bib12","doi-asserted-by":"crossref","first-page":"2640","DOI":"10.1182\/blood-2009-10-246959","article-title":"Adult T-cell leukemia\/lymphoma development in HTLV-1-infected humanized SCID mice","volume":"115","author":"Banerjee","year":"2010","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.prp.2024.155172_bib13","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.bbmt.2006.09.002","article-title":"Allogeneic Bone Marrow Transplantation from Unrelated Human T-Cell Leukemia Virus-I\u2013negative Donors for Adult T-Cell Leukemia\/Lymphoma: Retrospective Analysis of Data from the Japan Marrow Donor Program","volume":"13","author":"Kato","year":"2007","journal-title":"Biol. Blood Marrow Transplant."},{"issue":"11","key":"10.1016\/j.prp.2024.155172_bib14","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1111\/pin.12462","article-title":"Quantitative PCR for HTLV-1 provirus in adult T-cell leukemia\/lymphoma using paraffin tumor sections","volume":"66","author":"Kato","year":"2016","journal-title":"Pathol. Int"},{"issue":"12","key":"10.1016\/j.prp.2024.155172_bib15","doi-asserted-by":"crossref","first-page":"6604","DOI":"10.3390\/v7122960","article-title":"Recent advances in therapeutic approaches for adult T-cell leukemia\/lymphoma","volume":"7","author":"Kato","year":"2015","journal-title":"Viruses"},{"key":"10.1016\/j.prp.2024.155172_bib16","doi-asserted-by":"crossref","DOI":"10.1186\/1742-4690-6-S2-O24","article-title":"HTLV-1 infection of Humanized SCID mice recapitulates Adult T-cell Leukemia\/Lymphoma (ATLL) development","author":"Banerjee","year":"2009","journal-title":"Retrovirology"},{"issue":"5","key":"10.1016\/j.prp.2024.155172_bib17","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1038\/sj.leu.2403682","article-title":"Allogeneic hematopoietic stem cell transplantation provides sustained long-term survival for patients with adult T-cell leukemia\/lymphoma","volume":"19","author":"Fukushima","year":"2005","journal-title":"Leukemia"},{"issue":"3","key":"10.1016\/j.prp.2024.155172_bib18","doi-asserted-by":"crossref","first-page":"145","DOI":"10.3960\/jslrt.55.145","article-title":"TET2 Mutation in Adult T-Cell Leukemia\/Lymphoma","volume":"55","author":"Shimoda","year":"2015","journal-title":"J. Clin. Exp. Hematop"},{"issue":"8","key":"10.1016\/j.prp.2024.155172_bib19","doi-asserted-by":"crossref","DOI":"10.3390\/jcm9082417","article-title":"Allogeneic Stem Cell Transplantation for Adult T-Cell Leukemia\/Lymphoma-Romanian Experience","volume":"9","author":"Tanase","year":"2020","journal-title":"J. Clin. Med"},{"key":"10.1016\/j.prp.2024.155172_bib20","series-title":"Viruses and Human Cancer: From Basic Science to Clinical Prevention","first-page":"211","article-title":"Prevention of Human T-Cell Lymphotropic Virus Type 1 Infection and Adult T-Cell Leukemia\/Lymphoma","author":"Yoshimitsu","year":"2014"},{"issue":"10","key":"10.1016\/j.prp.2024.155172_bib21","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1182\/blood.2021012734","article-title":"Genome-wide CRISPR screen identifies CDK6 as a therapeutic target in adult T-cell leukemia\/lymphoma","volume":"139","author":"Ishio","year":"2022","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.prp.2024.155172_bib22","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1159\/000227067","article-title":"Effective treatment of adult T cell leukemia\/lymphoma with a novel oral antitumor agent, MST-16","volume":"49","author":"Ichihashi","year":"1992","journal-title":"Oncology"},{"issue":"4","key":"10.1016\/j.prp.2024.155172_bib23","article-title":"Shikonin Induces ROS-Dependent Apoptosis Via Mitochondria Depolarization and ER Stress in Adult T Cell Leukemia\/Lymphoma","volume":"12","author":"Boonnate","year":"2023","journal-title":"Antioxid. (Basel)"},{"issue":"Pt 12","key":"10.1016\/j.prp.2024.155172_bib24","doi-asserted-by":"crossref","first-page":"3177","DOI":"10.1099\/vir.0.19334-0","article-title":"The immune control and cell-to-cell spread of human T-lymphotropic virus type 1","volume":"84","author":"Bangham","year":"2003","journal-title":"J. Gen. Virol."},{"issue":"14","key":"10.1016\/j.prp.2024.155172_bib25","doi-asserted-by":"crossref","first-page":"3935","DOI":"10.2741\/3502","article-title":"Clonal expansion of HTLV-1 infected cells depends on the CD4 versus CD8 phenotype","volume":"10","author":"Zane","year":"2009","journal-title":"Front Biosci. (Landmark Ed. )"},{"issue":"8","key":"10.1016\/j.prp.2024.155172_bib26","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1038\/aps.2017.17","article-title":"Human T-cell lymphotropic virus type 1 and its oncogenesis","volume":"38","author":"Zhang","year":"2017","journal-title":"Acta Pharm. Sin."},{"issue":"16","key":"10.1016\/j.prp.2024.155172_bib27","doi-asserted-by":"crossref","first-page":"2994","DOI":"10.1182\/blood-2009-07-231050","article-title":"Immune activation induces immortalization of HTLV-1 LTR-Tax transgenic CD4+ T cells","volume":"116","author":"Swaims","year":"2010","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.prp.2024.155172_bib28","doi-asserted-by":"crossref","first-page":"2956","DOI":"10.1128\/JVI.77.5.2956-2963.2003","article-title":"Expansion of human T-cell leukemia virus type 1 (HTLV-1) reservoir in orally infected rats: inverse correlation with HTLV-1-specific cellular immune response","volume":"77","author":"Hasegawa","year":"2003","journal-title":"J. Virol."},{"key":"10.1016\/j.prp.2024.155172_bib29","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2017.02563","article-title":"Role of HTLV-1 Tax and HBZ in the Pathogenesis of HAM\/TSP","volume":"8","author":"Enose-Akahata","year":"2017","journal-title":"Front Microbiol"},{"issue":"6","key":"10.1016\/j.prp.2024.155172_bib30","doi-asserted-by":"crossref","DOI":"10.3390\/v8060171","article-title":"Transcriptional and Epigenetic Regulatory Mechanisms Affecting HTLV-1 Provirus","volume":"8","author":"Miyazato","year":"2016","journal-title":"Viruses"},{"key":"10.1016\/j.prp.2024.155172_bib31","doi-asserted-by":"crossref","first-page":"323","DOI":"10.3389\/fmicb.2012.00323","article-title":"The roles of acquired and innate immunity in human T-cell leukemia virus type 1-mediated diseases","volume":"3","author":"Kannagi","year":"2012","journal-title":"Front Microbiol"},{"key":"10.1016\/j.prp.2024.155172_bib32","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.virol.2013.11.022","article-title":"HTLV-1 infects human mesenchymal stromal cell in vitro and modifies their phenotypic characteristics","volume":"449","author":"Rodrigues","year":"2014","journal-title":"Virology"},{"issue":"11","key":"10.1016\/j.prp.2024.155172_bib33","doi-asserted-by":"crossref","DOI":"10.3390\/pathogens9110904","article-title":"Human T-cell Leukemia Virus Type 1 and Strongyloides stercoralis: Partners in Pathogenesis","volume":"9","author":"Dykie","year":"2020","journal-title":"Pathogens"},{"issue":"4","key":"10.1016\/j.prp.2024.155172_bib34","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1038\/nm1389","article-title":"Thymus-derived leukemia-lymphoma in mice transgenic for the Tax gene of human T-lymphotropic virus type I","volume":"12","author":"Hasegawa","year":"2006","journal-title":"Nat. Med"},{"issue":"7","key":"10.1016\/j.prp.2024.155172_bib35","doi-asserted-by":"crossref","first-page":"4441","DOI":"10.1074\/jbc.M109.031476","article-title":"Human T cell lymphotropic virus 1 manipulates interferon regulatory signals by controlling the TAK1-IRF3 and IRF4 pathways","volume":"285","author":"Suzuki","year":"2010","journal-title":"J. Biol. Chem."},{"issue":"10","key":"10.1016\/j.prp.2024.155172_bib36","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1002\/ijc.24664","article-title":"FoxP3+ regulatory T cells are distinct from leukemia cells in HTLV-1-associated adult T-cell leukemia","volume":"125","author":"Toulza","year":"2009","journal-title":"Int J. Cancer"},{"issue":"18","key":"10.1016\/j.prp.2024.155172_bib37","doi-asserted-by":"crossref","first-page":"3324","DOI":"10.1111\/febs.14492","article-title":"NF-\u03baB signaling mechanisms in HTLV-1-induced adult T-cell leukemia\/lymphoma","volume":"285","author":"Harhaj","year":"2018","journal-title":"FEBS J."},{"issue":"23","key":"10.1016\/j.prp.2024.155172_bib38","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1182\/blood.V126.23.1562.1562","article-title":"The Combination of Belinostat with Zidovudine for Treatment of HTLV-I Related Adult T-Cell Leukemia-Lymphoma","volume":"126","author":"Toomey","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.prp.2024.155172_bib39","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/1742-4690-5-9","article-title":"Human T Lymphotropic Virus Type 1 protein Tax reduces histone levels","volume":"5","author":"Bogenberger","year":"2008","journal-title":"Retrovirology"},{"issue":"2","key":"10.1016\/j.prp.2024.155172_bib40","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.ccell.2018.06.014","article-title":"Targeting the HTLV-I-Regulated BATF3\/IRF4 Transcriptional Network in Adult T Cell Leukemia\/Lymphoma","volume":"34","author":"Nakagawa","year":"2018","journal-title":"Cancer Cell"},{"issue":"4","key":"10.1016\/j.prp.2024.155172_bib41","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1038\/leu.2010.315","article-title":"LBH589, a deacetylase inhibitor, induces apoptosis in adult T-cell leukemia\/lymphoma cells via activation of a novel RAIDD-caspase-2 pathway","volume":"25","author":"Hasegawa","year":"2011","journal-title":"Leukemia"},{"issue":"4","key":"10.1016\/j.prp.2024.155172_bib42","doi-asserted-by":"crossref","first-page":"2048","DOI":"10.1128\/JVI.01264-08","article-title":"Upregulation of human T-cell leukemia virus type 1 antisense transcription by the viral tax protein","volume":"83","author":"Landry","year":"2009","journal-title":"J. Virol."},{"issue":"21","key":"10.1016\/j.prp.2024.155172_bib43","doi-asserted-by":"crossref","first-page":"6082","DOI":"10.1158\/0008-5472.CAN-13-3564","article-title":"HTLV-1 bZIP Factor HBZ Promotes Cell Proliferation and Genetic Instability by Activating OncomiRs","volume":"74","author":"Vernin","year":"2014","journal-title":"Cancer Res."},{"issue":"2","key":"10.1016\/j.prp.2024.155172_bib44","doi-asserted-by":"crossref","first-page":"106","DOI":"10.5045\/br.2017.52.2.106","article-title":"Evaluation of the role of TAX, HBZ, and HTLV-1 proviral load on the survival of ATLL patients","volume":"52","author":"Akbarin","year":"2017","journal-title":"Blood Res"},{"issue":"12","key":"10.1016\/j.prp.2024.155172_bib45","doi-asserted-by":"crossref","first-page":"2427","DOI":"10.1182\/blood-2008-09-179879","article-title":"Human T-cell leukemia virus type 2 produces a spliced antisense transcript encoding a protein that lacks a classic bZIP domain but still inhibits Tax2-mediated transcription","volume":"114","author":"Halin","year":"2009","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.prp.2024.155172_bib46","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1093\/infdis\/jir708","article-title":"HTLV-2 APH-2 expression is correlated with proviral load but APH-2 does not promote lymphocytosis","volume":"205","author":"Douceron","year":"2012","journal-title":"J. Infect. Dis."},{"issue":"9","key":"10.1016\/j.prp.2024.155172_bib47","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1009919","article-title":"The HTLV-1 viral oncoproteins Tax and HBZ reprogram the cellular mRNA splicing landscape","volume":"17","author":"Vandermeulen","year":"2021","journal-title":"PLoS Pathog."},{"issue":"4","key":"10.1016\/j.prp.2024.155172_bib48","doi-asserted-by":"crossref","first-page":"864","DOI":"10.3390\/antiox12040864","article-title":"Shikonin Induces ROS-Dependent Apoptosis Via Mitochondria Depolarization and ER Stress in Adult T Cell Leukemia\/Lymphoma","volume":"12","author":"Boonnate","year":"2023","journal-title":"Antioxidants"},{"issue":"14","key":"10.1016\/j.prp.2024.155172_bib49","doi-asserted-by":"crossref","first-page":"6178","DOI":"10.1128\/MCB.25.14.6178-6198.2005","article-title":"A human T-cell lymphotropic virus type 1 enhancer of Myc transforming potential stabilizes Myc-TIP60 transcriptional interactions","volume":"25","author":"Awasthi","year":"2005","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.prp.2024.155172_bib50","article-title":"Interaction network of African swine fever virus structural protein p30 with host proteins","volume":"13","author":"Chen","year":"2022","journal-title":"Front Microbiol"},{"issue":"7","key":"10.1016\/j.prp.2024.155172_bib51","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1111\/j.1349-7006.2011.01946.x","article-title":"Detection of HTLV-1 by means of HBZ gene in situ hybridization in formalin-fixed and paraffin-embedded tissues","volume":"102","author":"Shimizu-Kohno","year":"2011","journal-title":"Cancer Sci."},{"issue":"9","key":"10.1016\/j.prp.2024.155172_bib52","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1046\/j.1365-3024.2001.00407.x","article-title":"HTLV-1 decreases Th2 type of immune response in patients with strongyloidiasis","volume":"23","author":"Porto","year":"2001","journal-title":"Parasite Immunol."},{"issue":"1","key":"10.1016\/j.prp.2024.155172_bib53","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00126334-200105010-00001","article-title":"Cytokine profile and immunomodulation in asymptomatic human T-lymphotropic virus type 1-infected blood donors","volume":"27","author":"Carvalho","year":"2001","journal-title":"J. Acquir Immune Defic. Syndr."},{"key":"10.1016\/j.prp.2024.155172_bib54","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2334-4-7","article-title":"Exacerbated inflammatory cellular immune response characteristics of HAM\/TSP is observed in a large proportion of HTLV-I asymptomatic carriers","volume":"4","author":"Santos","year":"2004","journal-title":"BMC Infect. Dis."},{"issue":"3","key":"10.1016\/j.prp.2024.155172_bib55","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1111\/j.1365-2249.2008.03869.x","article-title":"Infective dermatitis has similar immunological features to human T lymphotropic virus-type 1-associated myelopathy\/tropical spastic paraparesis","volume":"156","author":"Nascimento","year":"2009","journal-title":"Clin. Exp. Immunol."},{"issue":"1","key":"10.1016\/j.prp.2024.155172_bib56","doi-asserted-by":"crossref","DOI":"10.1186\/s12977-019-0499-5","article-title":"Immunovirological markers in HTLV-1-associated myelopathy\/tropical spastic paraparesis (HAM\/TSP)","volume":"16","author":"Enose-Akahata","year":"2019","journal-title":"Retrovirology"},{"issue":"6","key":"10.1016\/j.prp.2024.155172_bib57","doi-asserted-by":"crossref","first-page":"2176","DOI":"10.1182\/blood-2008-06-163071","article-title":"HTLV-1 infection: role of CTL efficiency","volume":"112","author":"Bangham","year":"2008","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.prp.2024.155172_bib58","doi-asserted-by":"crossref","first-page":"809","DOI":"10.3899\/jrheum.111075","article-title":"Detection of HTLV-1 in the labial salivary glands of patients with Sj\u00f6gren\u2019s syndrome: a distinct clinical subgroup?","volume":"39","author":"Lee","year":"2012","journal-title":"J. Rheuma"},{"issue":"4","key":"10.1016\/j.prp.2024.155172_bib59","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0175345","article-title":"MAIT cells are reduced in frequency and functionally impaired in human T lymphotropic virus type 1 infection: Potential clinical implications","volume":"12","author":"Paquin-Proulx","year":"2017","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.prp.2024.155172_bib60","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1038\/leu.2008.272","article-title":"PD-1\/PD-L1 expression in human T-cell leukemia virus type 1 carriers and adult T-cell leukemia\/lymphoma patients","volume":"23","author":"Kozako","year":"2009","journal-title":"Leukemia"},{"issue":"5","key":"10.1016\/j.prp.2024.155172_bib61","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1002\/hon.2768","article-title":"Clinicopathological analysis of immunohistochemical expression of CD47 and SIRP\u03b1 in adult T-cell leukemia\/lymphoma","volume":"38","author":"Yanagida","year":"2020","journal-title":"Hematol. Oncol."},{"issue":"11","key":"10.1016\/j.prp.2024.155172_bib62","doi-asserted-by":"crossref","first-page":"3612","DOI":"10.1182\/blood.V97.11.3612","article-title":"Cytogenetic analysis and clinical significance in adult T-cell leukemia\/lymphoma: a study of 50 cases from the human T-cell leukemia virus type-1 endemic area, Nagasaki","volume":"97","author":"Itoyama","year":"2001","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.prp.2024.155172_bib63","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1111\/j.1365-2141.2008.07351.x","article-title":"Smouldering adult T-cell leukaemia\/lymphoma: a follow-up study in Kyushu","volume":"143","author":"Ishitsuka","year":"2008","journal-title":"Br. J. Haematol."},{"issue":"35","key":"10.1016\/j.prp.2024.155172_bib64","doi-asserted-by":"crossref","first-page":"4696","DOI":"10.1200\/JCO.2011.35.5578","article-title":"Use of zidovudine and interferon alfa with chemotherapy improves survival in both acute and lymphoma subtypes of adult T-cell leukemia\/lymphoma","volume":"29","author":"Hodson","year":"2011","journal-title":"J. Clin. Oncol."},{"issue":"6","key":"10.1016\/j.prp.2024.155172_bib65","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1111\/ijlh.13289","article-title":"TACC3 expression as a prognostic factor in aggressive types of adult T-cell leukemia\/lymphoma patients","volume":"42","author":"Moritsubo","year":"2020","journal-title":"Int J. Lab Hematol."},{"issue":"21","key":"10.1016\/j.prp.2024.155172_bib66","doi-asserted-by":"crossref","first-page":"5110","DOI":"10.1182\/blood.V120.21.5110.5110","article-title":"Adult T-Cell Leukemia\/Lymphoma in Peru: A Report of 120 Cases","volume":"120","author":"Beltran","year":"2012","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.prp.2024.155172_bib67","doi-asserted-by":"crossref","first-page":"13","DOI":"10.3960\/jslrt.55.13","article-title":"Mutation Analysis for TP53 in Chronic-Type Adult T-Cell Leukemia\/Lymphoma","volume":"55","author":"Yoshida","year":"2015","journal-title":"J. Clin. Exp. Hematop"},{"issue":"3","key":"10.1016\/j.prp.2024.155172_bib68","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1002\/ajh.20307","article-title":"Current views in HTLV-I-associated adult T-cell leukemia\/lymphoma","volume":"78","author":"Nicot","year":"2005","journal-title":"Am. J. Hematol."},{"issue":"10","key":"10.1016\/j.prp.2024.155172_bib69","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1111\/j.1365-4632.2010.04568.x","article-title":"Cutaneous manifestations associated with HTLV-1 infection","volume":"49","author":"Bittencourt","year":"2010","journal-title":"Int. J. Dermatol."},{"issue":"3","key":"10.1016\/j.prp.2024.155172_bib70","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1111\/j.1600-0609.2007.01016.x","article-title":"Treatment of adult T-cell leukemia\/lymphoma: past, present, and future","volume":"80","author":"Ishitsuka","year":"2008","journal-title":"Eur. J. Haematol."},{"issue":"Supplement_1","key":"10.1016\/j.prp.2024.155172_bib71","doi-asserted-by":"crossref","first-page":"S96","DOI":"10.1093\/ajcp\/aqaa161.211","article-title":"Single Institutional Experience on Cutaneous Manifestation of Adult T-cell Leukemia\/Lymphoma - Potential Diagnostic Pitfall","volume":"154","author":"Bridgelall","year":"2020","journal-title":"Am. J. Clin. Pathol."},{"issue":"2","key":"10.1016\/j.prp.2024.155172_bib72","doi-asserted-by":"crossref","first-page":"435","DOI":"10.4269\/ajtmh.17-0137","article-title":"Case Report: Orbital Tumor Revealing Adult T-Cell Leukemia\/Lymphoma Associated with Human T-Cell Lymphotropic Virus Type-1","volume":"99","author":"Far\u00e8s","year":"2018","journal-title":"Am. J. Trop. Med Hyg."},{"issue":"34","key":"10.1016\/j.prp.2024.155172_bib73","doi-asserted-by":"crossref","first-page":"5458","DOI":"10.1200\/JCO.2007.11.9958","article-title":"VCAP-AMP-VECP compared with biweekly CHOP for adult T-cell leukemia-lymphoma: Japan Clinical Oncology Group Study JCOG9801","volume":"25","author":"Tsukasaki","year":"2007","journal-title":"J. Clin. Oncol."},{"issue":"2","key":"10.1016\/j.prp.2024.155172_bib74","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1038\/bmt.2015.265","article-title":"Early application of related SCT might improve clinical outcome in adult T-cell leukemia\/lymphoma","volume":"51","author":"Fuji","year":"2016","journal-title":"Bone Marrow Transpl."},{"issue":"8","key":"10.1016\/j.prp.2024.155172_bib75","doi-asserted-by":"crossref","first-page":"2778","DOI":"10.1111\/cas.15431","article-title":"Oral histone deacetylase inhibitor tucidinostat (HBI-8000) in patients with relapsed or refractory adult T-cell leukemia\/lymphoma: Phase IIb results","volume":"113","author":"Utsunomiya","year":"2022","journal-title":"Cancer Sci."},{"key":"10.1016\/j.prp.2024.155172_bib76","article-title":"Pathologically Proven Intraocular Infiltration With Adult T-Cell Leukemia\/Lymphoma: Two New Cases With Either Vitreous Opacity or Aqueous Hypopyon and Literature Review of 16 Cases","volume":"8","author":"Matsuo","year":"2020","journal-title":"J. Invest. Med High. Impact Case Rep."},{"issue":"4","key":"10.1016\/j.prp.2024.155172_bib77","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1097\/00042560-199904010-00011","article-title":"Implication of HTLV-I infection, strongyloidiasis, and P53 overexpression in the development, response to treatment, and evolution of non-Hodgkin's lymphomas in an endemic area (Martinique, French West Indies)","volume":"20","author":"Agap\u00e9","year":"1999","journal-title":"J. Acquir Immune Defic. Syndr. Hum. Retrovirol"},{"issue":"5","key":"10.1016\/j.prp.2024.155172_bib78","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1038\/bmt.2015.315","article-title":"Pretransplant mogamulizumab against ATLL might increase the risk of acute GVHD and non-relapse mortality","volume":"51","author":"Inoue","year":"2016","journal-title":"Bone Marrow Transpl."},{"issue":"1","key":"10.1016\/j.prp.2024.155172_bib79","doi-asserted-by":"crossref","DOI":"10.1186\/s12985-023-02077-0","article-title":"Zidovudine and Interferon Alfa based regimens for the treatment of adult T-cell leukemia\/lymphoma (ATLL): a systematic review and meta-analysis","volume":"20","author":"Shafiee","year":"2023","journal-title":"Virol. J."},{"issue":"1","key":"10.1016\/j.prp.2024.155172_bib80","doi-asserted-by":"crossref","first-page":"e40","DOI":"10.1111\/1346-8138.14522","article-title":"S\u00e9zary syndrome in an anti-human T-cell lymphotropic virus type 1 seropositive carrier","volume":"46","author":"Baba","year":"2019","journal-title":"J. Dermatol."},{"issue":"3","key":"10.1016\/j.prp.2024.155172_bib81","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1002\/jha2.476","article-title":"Multiple polypoid lesions with erosion of the gastric mucosa in adult T-cell lymphoma\/leukemia superimposed on cytomegalovirus infection","volume":"3","author":"Shimazu","year":"2022","journal-title":"EJHaem"},{"issue":"5","key":"10.1016\/j.prp.2024.155172_bib82","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1111\/ejh.12863","article-title":"Effects of mogamulizumab in adult T-cell leukemia\/lymphoma in clinical practice","volume":"98","author":"Sekine","year":"2017","journal-title":"Eur. J. Haematol."},{"issue":"1","key":"10.1016\/j.prp.2024.155172_bib83","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1002\/hon.2242","article-title":"Late onset toxic epidermal necrolysis induced by mogamulizumab, an anti-CC chemokine receptor 4 antibody for the treatment of adult T-cell leukaemia\/lymphoma","volume":"35","author":"Shiratori","year":"2017","journal-title":"Hematol. Oncol."},{"key":"10.1016\/j.prp.2024.155172_bib84","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.2147\/OTT.S165615","article-title":"Mogamulizumab: a new tool for management of cutaneous T-cell lymphoma","volume":"12","author":"Ollila","year":"2019","journal-title":"Onco Targets Ther."},{"issue":"6","key":"10.1016\/j.prp.2024.155172_bib85","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1111\/1346-8138.12852","article-title":"CCR4 is expressed on infiltrating cells in lesional skin of early mycosis fungoides and atopic dermatitis","volume":"42","author":"Sugaya","year":"2015","journal-title":"J. Dermatol."},{"issue":"6","key":"10.1016\/j.prp.2024.155172_bib86","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1001\/jamadermatol.2021.0877","article-title":"Clinical Characterization of Mogamulizumab-Associated Rash During Treatment of Mycosis Fungoides or S\u00e9zary Syndrome","volume":"157","author":"Hirotsu","year":"2021","journal-title":"JAMA Dermatol."},{"issue":"2","key":"10.1016\/j.prp.2024.155172_bib87","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1080\/10428194.2021.1984455","article-title":"An international, multicenter, retrospective study on the positive impact of cutaneous involvement on the clinical outcome of adult T-cell leukemia\/lymphoma","volume":"63","author":"Malpica","year":"2022","journal-title":"Leuk. Lymphoma"},{"issue":"7","key":"10.1016\/j.prp.2024.155172_bib88","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.3109\/10428191003728628","article-title":"Expression profiles of adult T-cell leukemia-lymphoma and associations with clinical responses to zidovudine and interferon alpha","volume":"51","author":"Alizadeh","year":"2010","journal-title":"Leuk. Lymphoma"},{"issue":"4","key":"10.1016\/j.prp.2024.155172_bib89","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/s11899-012-0139-9","article-title":"\"Antivirals\" in the treatment of adult T cell leukaemia- lymphoma (ATLL)","volume":"7","author":"Fields","year":"2012","journal-title":"Curr. Hematol. Malig. Rep."},{"issue":"2","key":"10.1016\/j.prp.2024.155172_bib90","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1080\/10428190601071717","article-title":"Zidovudine and interferon-alpha treatment induces a high response rate and reduces HTLV-1 proviral load and VEGF plasma levels in patients with adult T-cell leukemia from North East Iran","volume":"48","author":"Kchour","year":"2007","journal-title":"Leuk. Lymphoma"},{"issue":"3","key":"10.1016\/j.prp.2024.155172_bib91","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1080\/10428190400019966","article-title":"In vivo and in vitro treatment of HTLV-1 and HTLV-2 infected cells with arsenic trioxide and interferon-alpha","volume":"46","author":"Mahieux","year":"2005","journal-title":"Leuk. Lymphoma"},{"issue":"4","key":"10.1016\/j.prp.2024.155172_bib92","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1007\/s11899-007-0035-x","article-title":"Adult T-cell leukemia\/lymphoma and HTLV-1","volume":"2","author":"Mahieux","year":"2007","journal-title":"Curr. Hematol. Malig. Rep."},{"issue":"12","key":"10.1016\/j.prp.2024.155172_bib93","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1080\/1042819021000039983","article-title":"Treatment of adult T-cell leukemia-lymphoma by CHOP followed by therapy with antinucleosides, alpha interferon and oral etoposide","volume":"43","author":"Besson","year":"2002","journal-title":"Leuk. Lymphoma"},{"issue":"1","key":"10.1016\/j.prp.2024.155172_bib94","doi-asserted-by":"crossref","first-page":"omx081","DOI":"10.1093\/omcr\/omx081","article-title":"HTLV-1, ATLL, refractory hypercalcaemia and HIV-1 co-infection","volume":"2018","author":"Laher","year":"2018","journal-title":"Oxf. Med Case Rep."},{"issue":"3","key":"10.1016\/j.prp.2024.155172_bib95","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1182\/blood-2006-05-024810","article-title":"Never say never again!","volume":"108","author":"Apperley","year":"2006","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.prp.2024.155172_bib96","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1182\/blood-2018-01-791335","article-title":"Allogeneic hematopoietic stem cell transplantation for T-cell lymphomas","volume":"132","author":"Schmitz","year":"2018","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.prp.2024.155172_bib97","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1016\/j.bbmt.2016.05.017","article-title":"Mogamulizumab Treatment Prior to Allogeneic Hematopoietic Stem Cell Transplantation Induces Severe Acute Graft-versus-Host Disease","volume":"22","author":"Sugio","year":"2016","journal-title":"Biol. Blood Marrow Transpl."},{"key":"10.1016\/j.prp.2024.155172_bib98","doi-asserted-by":"crossref","DOI":"10.1186\/1742-4690-7-8","article-title":"Hematopoietic stem cells and retroviral infection","volume":"7","author":"Banerjee","year":"2010","journal-title":"Retrovirology"},{"key":"10.1016\/j.prp.2024.155172_bib99","doi-asserted-by":"crossref","first-page":"70","DOI":"10.21037\/sci.2016.09.13","article-title":"Friend or foe? Mogamulizumab in allogeneic hematopoietic stem cell transplantation for adult T-cell leukemia\/lymphoma","volume":"3","author":"Fuji","year":"2016","journal-title":"Stem Cell Invest."},{"issue":"11","key":"10.1016\/j.prp.2024.155172_bib100","doi-asserted-by":"crossref","DOI":"10.1038\/bcj.2013.57","article-title":"Association between decreasing trend in the mortality of adult T-cell leukemia\/lymphoma and allogeneic hematopoietic stem cell transplants in Japan: analysis of Japanese vital statistics and Japan Society for Hematopoietic Cell Transplantation (JSHCT)","volume":"3","author":"Chihara","year":"2013","journal-title":"Blood Cancer J."},{"issue":"6","key":"10.1016\/j.prp.2024.155172_bib101","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1007\/s12185-012-1056-3","article-title":"Successful treatment by donor lymphocyte infusion of adult T-cell leukemia\/lymphoma relapse following allogeneic hematopoietic stem cell transplantation","volume":"95","author":"Kamimura","year":"2012","journal-title":"Int. J. Hematol."},{"issue":"11","key":"10.1016\/j.prp.2024.155172_bib102","doi-asserted-by":"crossref","first-page":"2862","DOI":"10.1038\/s41409-021-01432-5","article-title":"Treatment of relapsed aggressive adult T-cell leukemia\/lymphoma after allogeneic hematopoietic stem cell transplantation with mogamulizumab followed by lenalidomide","volume":"56","author":"Tamai","year":"2021","journal-title":"Bone Marrow Transplant."},{"issue":"6","key":"10.1016\/j.prp.2024.155172_bib103","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1038\/leu.2012.321","article-title":"Comparison of outcomes between autologous and allogeneic hematopoietic stem cell transplantation for peripheral T-cell lymphomas with central review of pathology","volume":"27","author":"Kim","year":"2013","journal-title":"Leukemia"},{"issue":"2","key":"10.1016\/j.prp.2024.155172_bib104","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1007\/s12185-013-1387-8","article-title":"Successful treatment of a patient with adult T cell leukemia\/lymphoma using anti-CC chemokine receptor 4 monoclonal antibody mogamulizumab followed by allogeneic hematopoietic stem cell transplantation","volume":"98","author":"Motohashi","year":"2013","journal-title":"Int. J. Hematol."},{"issue":"12","key":"10.1016\/j.prp.2024.155172_bib105","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1038\/bmt.2014.204","article-title":"High incidence of CMV infection in adult T-cell leukemia\/lymphoma patients after allogeneic hematopoietic stem cell transplantation","volume":"49","author":"Nakano","year":"2014","journal-title":"Bone Marrow Transpl."},{"issue":"10","key":"10.1016\/j.prp.2024.155172_bib106","doi-asserted-by":"crossref","DOI":"10.3390\/cancers11101420","article-title":"Monoclonal Antibodies in Dermatooncology-State of the Art and Future Perspectives","volume":"11","author":"Bobrowicz","year":"2019","journal-title":"Cancers (Basel)"},{"issue":"7","key":"10.1016\/j.prp.2024.155172_bib107","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1182\/blood-2007-02-071423","article-title":"Donor-derived DNA in fingernails among recipients of allogeneic hematopoietic stem-cell transplants","volume":"110","author":"Imanishi","year":"2007","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.prp.2024.155172_bib108","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1007\/s12185-016-2087-y","article-title":"Successful treatment with mogamulizumab followed by allogeneic hematopoietic stem-cell transplantation in adult T-cell leukemia\/lymphoma: a report of two cases","volume":"104","author":"Tsubokura","year":"2016","journal-title":"Int J. Hematol."},{"issue":"6","key":"10.1016\/j.prp.2024.155172_bib109","doi-asserted-by":"crossref","first-page":"e199","DOI":"10.1016\/j.bbmt.2019.02.004","article-title":"Barriers to Allogeneic Hematopoietic Stem Cell Transplantation for Human T Cell Lymphotropic Virus 1-Associated Adult T Cell Lymphoma-Leukemia in the United States: Experience from a Large Cohort in a Major Tertiary Center","volume":"25","author":"Adrianzen Herrera","year":"2019","journal-title":"Biol. Blood Marrow Transpl."},{"issue":"7","key":"10.1016\/j.prp.2024.155172_bib110","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/j.bbmt.2008.04.014","article-title":"A Retrospective Analysis of Allogeneic Hematopoietic Stem Cell Transplantation for Adult T Cell Leukemia\/Lymphoma (ATL): Clinical Impact of Graft-versus-Leukemia\/Lymphoma Effect","volume":"14","author":"Shiratori","year":"2008","journal-title":"Biol. Blood Marrow Transplant."},{"issue":"3","key":"10.1016\/j.prp.2024.155172_bib111","doi-asserted-by":"crossref","DOI":"10.1111\/tid.12682","article-title":"Risk factors of human herpesvirus 6 encephalitis\/myelitis after allogeneic hematopoietic stem cell transplantation","volume":"19","author":"Miyashita","year":"2017","journal-title":"Transpl. Infect. Dis."},{"issue":"Supplement 1","key":"10.1016\/j.prp.2024.155172_bib112","doi-asserted-by":"crossref","first-page":"4641","DOI":"10.1182\/blood-2018-99-114111","article-title":"Impact of Pretransplant HTLV-1 Seropositivity on Hematopoietic Stem Cell Transplantation for the Diseases Other Than ATLL- an Analysis on Behalf of JSHCT Complication Working Group","volume":"132","author":"Nakano","year":"2018","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.prp.2024.155172_bib113","doi-asserted-by":"crossref","first-page":"81","DOI":"10.14740\/jh973","article-title":"Transmission of Human T-Lymphotropic Virus Type I to Donor-Origin T Cells During Allogeneic Hematopoietic Stem Cell Transplantation","volume":"11","author":"Hirosawa","year":"2022","journal-title":"J. Hematol."},{"issue":"4","key":"10.1016\/j.prp.2024.155172_bib114","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1016\/j.bbrc.2007.10.070","article-title":"Stem cell properties and the side population cells as a target for interferon-alpha in adult T-cell leukemia\/lymphoma","volume":"364","author":"Kayo","year":"2007","journal-title":"Biochem Biophys. Res Commun."},{"issue":"10","key":"10.1016\/j.prp.2024.155172_bib115","doi-asserted-by":"crossref","first-page":"2521","DOI":"10.1080\/10428194.2021.1919665","article-title":"Efficacy of lenalidomide for relapsed or refractory T lymphoblastic lymphoma\/leukemia after allogeneic hematopoietic stem cell transplantation","volume":"62","author":"Liang","year":"2021","journal-title":"Leuk. Lymphoma"},{"issue":"7","key":"10.1016\/j.prp.2024.155172_bib116","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1016\/j.bbmt.2019.02.025","article-title":"Thiotepa, Busulfan, and Fludarabine Conditioning Regimen in T Cell-Replete HLA-Haploidentical Hematopoietic Stem Cell Transplantation","volume":"25","author":"Dul\u00e9ry","year":"2019","journal-title":"Biol. Blood Marrow Transpl."},{"issue":"5","key":"10.1016\/j.prp.2024.155172_bib117","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1038\/s41409-017-0086-0","article-title":"Syngeneic hematopoietic stem cell transplantation from HTLV-1 seropositive twin for adult T-cell leukemia-lymphoma","volume":"53","author":"Lahoud","year":"2018","journal-title":"Bone Marrow Transpl."},{"key":"10.1016\/j.prp.2024.155172_bib118","series-title":"Mogamulizumab for the treatment of adult T-cell leukemia\/lymphoma","author":"Yoshimitsu","year":"2014"},{"key":"10.1016\/j.prp.2024.155172_bib119","author":"Pornkuna","year":"2015","journal-title":"Clin. Value Serum Soluble CD 30 Lev. Adult T-Cell Leuk. \/ Lymphoma"},{"issue":"1","key":"10.1016\/j.prp.2024.155172_bib120","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.repc.2012.05.014","article-title":"Terapia celular card\u00edaca com c\u00e9lulas mesenquimatosas","volume":"32","author":"Lopes","year":"2013","journal-title":"Rev. Port. De. Cardiol."},{"key":"10.1016\/j.prp.2024.155172_bib121","doi-asserted-by":"crossref","unstructured":"Wu P., Yang M., Hao Y., Feng S., Li J. C35431Stem Cell Therapy for Spinal Cord Injury. 2018 [cited 6\/13\/2023]. In: Neurotrauma: A Comprehensive Textbook on Traumatic Brain Injury and Spinal Cord Injury [Internet]. Oxford University Press, [cited 6\/13\/2023]; [0]. Available from: \u3008https:\/\/doi.org\/10.1093\/med\/9780190279431.003.0035\u3009.","DOI":"10.1093\/med\/9780190279431.001.0001"},{"key":"10.1016\/j.prp.2024.155172_bib122","author":"Salah Berkane*","year":"2020","journal-title":"Malig. Transform. Into Chondrosarcoma A Retroperitoneal Residual Mass Chemother. A Testic. Semin. (Germinal Cell Tumor)"},{"issue":"3","key":"10.1016\/j.prp.2024.155172_bib123","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1097\/00062752-199905000-00010","article-title":"Progress in the development of systems for in vitro expansion of human hematopoietic stem cells","volume":"6","author":"Hoffman","year":"1999","journal-title":"Curr. Opin. Hematol."},{"key":"10.1016\/j.prp.2024.155172_bib124","doi-asserted-by":"crossref","first-page":"167","DOI":"10.2147\/TACG.S178546","article-title":"Gene Therapy For Beta-Thalassemia: Updated Perspectives","volume":"12","author":"Karponi","year":"2019","journal-title":"Appl. Clin. Genet"},{"issue":"8","key":"10.1016\/j.prp.2024.155172_bib125","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1182\/blood-2012-03-414490","article-title":"Allogeneic hematopoietic stem cell transplantation for adult T-cell leukemia-lymphoma with special emphasis on preconditioning regimen: a nationwide retrospective study","volume":"120","author":"Ishida","year":"2012","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.prp.2024.155172_bib126","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1200\/JCO.2008.18.2428","article-title":"Definition, prognostic factors, treatment, and response criteria of adult T-cell leukemia-lymphoma: a proposal from an international consensus meeting","volume":"27","author":"Tsukasaki","year":"2009","journal-title":"J. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.prp.2024.155172_bib127","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.bbmt.2013.10.021","article-title":"Long-Term Outcomes of Alemtuzumab-Based Reduced-Intensity Conditioned Hematopoietic Stem Cell Transplantation for Myelodysplastic Syndrome and Acute Myelogenous Leukemia Secondary to Myelodysplastic Syndrome","volume":"20","author":"Potter","year":"2014","journal-title":"Biol. Blood Marrow Transplant."},{"issue":"8","key":"10.1016\/j.prp.2024.155172_bib128","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1200\/JCO.2011.37.3472","article-title":"Defucosylated anti-CCR4 monoclonal antibody (KW-0761) for relapsed adult T-cell leukemia-lymphoma: a multicenter phase II study","volume":"30","author":"Ishida","year":"2012","journal-title":"J. Clin. Oncol."},{"issue":"10","key":"10.1016\/j.prp.2024.155172_bib129","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1016\/j.bbmt.2015.05.026","article-title":"Maintenance Therapy with Decitabine after Allogeneic Stem Cell Transplantation for Acute Myelogenous Leukemia and Myelodysplastic Syndrome","volume":"21","author":"Pusic","year":"2015","journal-title":"Biol. Blood Marrow Transpl."},{"issue":"4","key":"10.1016\/j.prp.2024.155172_bib130","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1182\/blood-2004-05-1947","article-title":"Comparative outcome of nonmyeloablative and myeloablative allogeneic hematopoietic cell transplantation for patients older than 50 years of age","volume":"105","author":"Alyea","year":"2005","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.prp.2024.155172_bib131","doi-asserted-by":"crossref","first-page":"373","DOI":"10.4103\/0255-0857.99512","article-title":"Ileocolic mucormycosis causing intestinal obstruction","volume":"30","author":"Chawla","year":"2012","journal-title":"Indian J. Med Microbiol"},{"issue":"34","key":"10.1016\/j.prp.2024.155172_bib132","doi-asserted-by":"crossref","first-page":"4086","DOI":"10.1200\/JCO.2016.67.7732","article-title":"Multicenter Phase II Study of Lenalidomide in Relapsed or Recurrent Adult T-Cell Leukemia\/Lymphoma: ATLL-002","volume":"34","author":"Ishida","year":"2016","journal-title":"J. Clin. Oncol."},{"issue":"6","key":"10.1016\/j.prp.2024.155172_bib133","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1016\/j.jaad.2015.01.003","article-title":"Hematopoietic stem cell transplantation for primary cutaneous \u03b3\u03b4 T-cell lymphoma and refractory subcutaneous panniculitis-like T-cell lymphoma","volume":"72","author":"Gibson","year":"2015","journal-title":"J. Am. Acad. Dermatol."},{"issue":"6","key":"10.1016\/j.prp.2024.155172_bib134","doi-asserted-by":"crossref","first-page":"493.e1","DOI":"10.1016\/j.jtct.2021.03.014","article-title":"Allogeneic Stem Cell Transplantation in Mature T Cell and Natural Killer\/T Neoplasias: A Registry Study from Spanish GETH\/GELTAMO Centers","volume":"27","author":"Novelli","year":"2021","journal-title":"Transpl. Cell Ther."},{"issue":"8","key":"10.1016\/j.prp.2024.155172_bib135","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1200\/JCO.18.00501","article-title":"Revised Adult T-Cell Leukemia-Lymphoma International Consensus Meeting Report","volume":"37","author":"Cook","year":"2019","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.prp.2024.155172_bib136","doi-asserted-by":"crossref","DOI":"10.1186\/1750-1172-2-35","article-title":"Acute graft versus host disease","volume":"2","author":"Jacobsohn","year":"2007","journal-title":"Orphanet J. Rare Dis."},{"issue":"12","key":"10.1016\/j.prp.2024.155172_bib137","doi-asserted-by":"crossref","first-page":"2346","DOI":"10.1016\/j.bbmt.2020.07.032","article-title":"Impact of Donor Source on Allogeneic Hematopoietic Stem Cell Transplantation for Mature T Cell and Natural Killer Cell Neoplasms in the Kyoto Stem Cell Transplantation Group","volume":"26","author":"Watanabe","year":"2020","journal-title":"Biol. Blood Marrow Transpl."},{"key":"10.1016\/j.prp.2024.155172_bib138","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.biomaterials.2014.11.020","article-title":"Immunomodulation by mesenchymal stem cells combats the foreign body response to cell-laden synthetic hydrogels","volume":"41","author":"Swartzlander","year":"2015","journal-title":"Biomaterials"},{"issue":"1","key":"10.1016\/j.prp.2024.155172_bib139","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1634\/stemcells.2007-0563","article-title":"Toll-like receptors on human mesenchymal stem cells drive their migration and immunomodulating responses","volume":"26","author":"Tomchuck","year":"2008","journal-title":"Stem Cells"},{"issue":"1","key":"10.1016\/j.prp.2024.155172_bib140","doi-asserted-by":"crossref","DOI":"10.1186\/s13287-017-0528-z","article-title":"Human and feline adipose-derived mesenchymal stem cells have comparable phenotype, immunomodulatory functions, and transcriptome","volume":"8","author":"Clark","year":"2017","journal-title":"Stem Cell Res Ther."},{"issue":"5","key":"10.1016\/j.prp.2024.155172_bib141","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.jcyt.2021.11.009","article-title":"Strategies to enhance immunomodulatory properties and reduce heterogeneity in mesenchymal stromal cells during ex vivo expansion","volume":"24","author":"Srinivasan","year":"2022","journal-title":"Cytotherapy"},{"issue":"5","key":"10.1016\/j.prp.2024.155172_bib142","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1111\/apt.13717","article-title":"The safety of autologous and metabolically fit bone marrow mesenchymal stromal cells in medically refractory Crohn's disease - a phase 1 trial with three doses","volume":"44","author":"Dhere","year":"2016","journal-title":"Aliment Pharm. Ther."},{"issue":"1","key":"10.1016\/j.prp.2024.155172_bib143","doi-asserted-by":"crossref","DOI":"10.1186\/s12917-022-03303-7","article-title":"Topical applications of allogeneic adipose-derived mesenchymal stem cells ameliorate the canine keratoconjunctivitis sicca","volume":"18","author":"Wei","year":"2022","journal-title":"BMC Vet. Res"},{"issue":"1","key":"10.1016\/j.prp.2024.155172_bib144","doi-asserted-by":"crossref","DOI":"10.1186\/s12977-016-0307-4","article-title":"ATL-derived exosomes modulate mesenchymal stem cells: potential role in leukemia progression","volume":"13","author":"El-Saghir","year":"2016","journal-title":"Retrovirology"},{"issue":"1","key":"10.1016\/j.prp.2024.155172_bib145","doi-asserted-by":"crossref","DOI":"10.1186\/s12964-022-00822-6","article-title":"The mechanisms of mutual relationship between malignant hematologic cells and mesenchymal stem cells: Does it contradict the nursing role of mesenchymal stem cells?","volume":"20","author":"Goodarzi","year":"2022","journal-title":"Cell Commun. Signal"},{"issue":"12","key":"10.1016\/j.prp.2024.155172_bib146","doi-asserted-by":"crossref","first-page":"2826","DOI":"10.1021\/nl0619711","article-title":"Quantum dots for human mesenchymal stem cells labeling. A size-dependent autophagy activation","volume":"6","author":"Seleverstov","year":"2006","journal-title":"Nano Lett."},{"issue":"11","key":"10.1016\/j.prp.2024.155172_bib147","first-page":"1583","article-title":"Mesenchymal stem cells promote caspase-3 expression of SH-SY5Y neuroblastoma cells via reducing telomerase activity and telomere length","volume":"24","author":"Fathi","year":"2021","journal-title":"Iran. J. Basic Med Sci."},{"issue":"5","key":"10.1016\/j.prp.2024.155172_bib148","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.it.2007.03.001","article-title":"Mesenchymal stem cells: a new strategy for immunosuppression?","volume":"28","author":"Uccelli","year":"2007","journal-title":"Trends Immunol."},{"issue":"8","key":"10.1016\/j.prp.2024.155172_bib149","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1097\/01.TP.0000082540.43730.80","article-title":"Mesenchymal stem cells inhibit the formation of cytotoxic T lymphocytes, but not activated cytotoxic T lymphocytes or natural killer cells","volume":"76","author":"Rasmusson","year":"2003","journal-title":"Transplantation"},{"issue":"4","key":"10.1016\/j.prp.2024.155172_bib150","doi-asserted-by":"crossref","DOI":"10.3390\/cells9040873","article-title":"IL7-IL12 Engineered Mesenchymal Stem Cells (MSCs) Improve A CAR T Cell Attack Against Colorectal Cancer Cells","volume":"9","author":"Hombach","year":"2020","journal-title":"Cells"},{"issue":"1","key":"10.1016\/j.prp.2024.155172_bib151","doi-asserted-by":"crossref","DOI":"10.1186\/s13045-018-0554-z","article-title":"Cell adhesion-mediated mitochondria transfer contributes to mesenchymal stem cell-induced chemoresistance on T cell acute lymphoblastic leukemia cells","volume":"11","author":"Wang","year":"2018","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.prp.2024.155172_bib152","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.761616","article-title":"Mesenchymal stromal cells for the treatment of graft versus host disease","volume":"12","author":"Kelly","year":"2021","journal-title":"Front Immunol."},{"issue":"2","key":"10.1016\/j.prp.2024.155172_bib153","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.cellimm.2008.04.009","article-title":"The immunosuppressive effects of human bone marrow-derived mesenchymal stem cells target T cell proliferation but not its effector function","volume":"251","author":"Ramasamy","year":"2008","journal-title":"Cell Immunol."},{"issue":"3","key":"10.1016\/j.prp.2024.155172_bib154","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s12308-012-0160-x","article-title":"XVI meeting of the European Association for Haematopathology 2012 Abstracts","volume":"5","year":"2012","journal-title":"J. Hematop."},{"issue":"1","key":"10.1016\/j.prp.2024.155172_bib155","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.ymgme.2011.10.002","article-title":"Developing treatment options for metachromatic leukodystrophy","volume":"105","author":"Batzios","year":"2012","journal-title":"Mol. Genet Metab."},{"issue":"6","key":"10.1016\/j.prp.2024.155172_bib156","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1002\/stem.68","article-title":"Mesenchymal stem cell transplantation reverses multiorgan dysfunction in systemic lupus erythematosus mice and humans","volume":"27","author":"Sun","year":"2009","journal-title":"Stem Cells"},{"key":"10.1016\/j.prp.2024.155172_bib157","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1016\/j.biopha.2018.10.137","article-title":"Ankylosing spondylitis and mesenchymal stromal\/stem cell therapy: a new therapeutic approach","volume":"109","author":"Abdolmohammadi","year":"2019","journal-title":"Biomed. Pharm."},{"issue":"5","key":"10.1016\/j.prp.2024.155172_bib158","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1177\/1759720X12447705","article-title":"Novel approaches in the treatment of myositis and myopathies","volume":"4","author":"Albayda","year":"2012","journal-title":"Ther. Adv. Musculoskelet. Dis."},{"issue":"1","key":"10.1016\/j.prp.2024.155172_bib159","doi-asserted-by":"crossref","DOI":"10.1186\/s12964-022-01028-6","article-title":"Mesenchymal stromal cell-associated migrasomes: a new source of chemoattractant for cells of hematopoietic origin","volume":"21","author":"Deniz","year":"2023","journal-title":"Cell Commun. Signal"},{"issue":"1","key":"10.1016\/j.prp.2024.155172_bib160","doi-asserted-by":"crossref","first-page":"183","DOI":"10.4049\/jimmunol.0903846","article-title":"Human T-lymphotropic virus type 1-induced CC chemokine ligand 22 maintains a high frequency of functional FoxP3+ regulatory T cells","volume":"185","author":"Toulza","year":"2010","journal-title":"J. Immunol."},{"key":"10.1016\/j.prp.2024.155172_bib161","doi-asserted-by":"crossref","first-page":"333","DOI":"10.3389\/fmicb.2012.00333","article-title":"Animal models on HTLV-1 and related viruses: what did we learn?","volume":"3","author":"Hajj","year":"2012","journal-title":"Front Microbiol"},{"issue":"Suppl. 1","key":"10.1016\/j.prp.2024.155172_bib162","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1159\/000431058","article-title":"Molecular pathology of adult T-cell leukemia\/lymphoma","volume":"89","author":"Ohshima","year":"2015","journal-title":"Oncology"},{"issue":"21","key":"10.1016\/j.prp.2024.155172_bib163","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1182\/blood.V124.21.1648.1648","article-title":"Cytotoxic T-lymphocyte analysis of aggressive types of adult T-cell leukemia\/lymphoma patients with complete remission after intensive combination chemotherapy","volume":"124","author":"Jo","year":"2014","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.prp.2024.155172_bib164","doi-asserted-by":"crossref","first-page":"702","DOI":"10.3109\/10428191003646697","article-title":"Osteolytic bone resorption in adult T-cell leukemia\/lymphoma","volume":"51","author":"Shu","year":"2010","journal-title":"Leuk. Lymphoma"},{"issue":"10","key":"10.1016\/j.prp.2024.155172_bib165","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1111\/1346-8138.12980","article-title":"Human T-lymphotropic virus 1 (HTLV-1)-associated lichenoid dermatitis induced by CD8+ T cells in HTLV-1 carrier, HTLV-1-associated myelopathy\/tropical spastic paraparesis and adult T-cell leukemia\/lymphoma","volume":"42","author":"Tokura","year":"2015","journal-title":"J. Dermatol."},{"issue":"2","key":"10.1016\/j.prp.2024.155172_bib166","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1097\/INF.0b013e31827efc39","article-title":"Mother-to-child transmission of human T-cell lymphotropic virus type 1","volume":"32","author":"Moriuchi","year":"2013","journal-title":"Pedia Infect. Dis. J."},{"key":"10.1016\/j.prp.2024.155172_bib167","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/5171032","article-title":"Recent updates on induced pluripotent stem cells in hematological disorders","volume":"2019","author":"Wattanapanitch","year":"2019","journal-title":"Stem Cells Int."},{"key":"10.1016\/j.prp.2024.155172_bib168","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.neurobiolaging.2019.02.008","article-title":"Using stem cell-derived neurons in drug screening for neurological diseases","volume":"78","author":"Little","year":"2019","journal-title":"Neurobiol. Aging"},{"issue":"1","key":"10.1016\/j.prp.2024.155172_bib169","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-64193-z","article-title":"Evaluation of the effects of cell-dispensing using an inkjet-based bioprinter on cell integrity by RNA-seq analysis","volume":"10","author":"Yumoto","year":"2020","journal-title":"Sci. Rep."},{"issue":"7","key":"10.1016\/j.prp.2024.155172_bib170","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1002\/stem.2637","article-title":"Concise review: induced pluripotent stem cell-based drug discovery for mitochondrial disease","volume":"35","author":"Inak","year":"2017","journal-title":"Stem Cells"},{"issue":"24","key":"10.1016\/j.prp.2024.155172_bib171","doi-asserted-by":"crossref","first-page":"2826","DOI":"10.2174\/0929867324666170804150131","article-title":"Induced Pluripotent Stem Cells as a Model for Therapy Personalization of Pediatric Patients: Disease Modeling and Drug Adverse Effects Prevention","volume":"25","author":"Genova","year":"2018","journal-title":"Curr. Med Chem."},{"issue":"10","key":"10.1016\/j.prp.2024.155172_bib172","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1038\/nbt.2678","article-title":"Generation of tumor-targeted human T lymphocytes from induced pluripotent stem cells for cancer therapy","volume":"31","author":"Themeli","year":"2013","journal-title":"Nat. Biotechnol."},{"issue":"10-11","key":"10.1016\/j.prp.2024.155172_bib173","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1038\/s41434-020-0179-z","article-title":"Sufficiency for inducible Caspase-9 safety switch in human pluripotent stem cells and disease cells","volume":"27","author":"Nishimura","year":"2019","journal-title":"Gene Ther."},{"issue":"2","key":"10.1016\/j.prp.2024.155172_bib174","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1007\/s12185-013-1387-8","article-title":"Successful treatment of a patient with adult T cell leukemia\/lymphoma using anti-CC chemokine receptor 4 monoclonal antibody mogamulizumab followed by allogeneic hematopoietic stem cell transplantation","volume":"98","author":"Motohashi","year":"2013","journal-title":"Int J. Hematol."}],"container-title":["Pathology - Research and Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033824000839?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033824000839?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T07:09:08Z","timestamp":1759734548000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0344033824000839"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":174,"alternative-id":["S0344033824000839"],"URL":"https:\/\/doi.org\/10.1016\/j.prp.2024.155172","relation":{},"ISSN":["0344-0338"],"issn-type":[{"value":"0344-0338","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Stem cell therapy for HTLV-1 induced adult T-cell leukemia\/lymphoma (ATLL): A comprehensive review","name":"articletitle","label":"Article Title"},{"value":"Pathology - Research and Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prp.2024.155172","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier GmbH. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"155172"}}